International Stem Cell CORP·4

Mar 14, 4:17 PM ET

Semechkin Andrey 4

4 · International Stem Cell CORP · Filed Mar 14, 2018

Insider Transaction Report

Form 4
Period: 2018-03-12
Semechkin Andrei
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-03-12+200,000200,000 total
    Exercise: $1.51Exp: 2028-03-12Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]3/36th of the shares underlying such options shall vest on June 12, 2018, and the remaining share in equal monthly installments over a period of 33 months.

Documents

1 file
  • 4
    andrey_f4.xmlPrimary

    OWNERSHIP DOCUMENT